Scientists have developed a test that uses cells from a single donor’s blood to predict whether a new drug will cause a severe reaction in humans.
The test could avert disasters like the 2006 trial of the drug TGN1412, which led to six healthy young men being admitted to intensive care with multiple organ failure. The volunteers receiving TGN1412 experienced a catastrophic inflammatory reaction called a cytokine storm.
Cytokine storm reactions are a particular worry for new biological therapies, or “biologics”, which use biological material such as antibodies. Many blockbuster drugs such as the cancer drugs Herceptin and Avastin are biologics, as are around a third of medicines in the pharmaceutical pipeline. Because these medicines are specific to humans, they can cause severe reactions that don’t materialise in animal studies, so tests on human cells are essential.
However, cytokine storm side effects are hard to predict with tests were just one cell type is used, since they depend on interactions between blood cells and endothelial cells, which form the lining of blood vessels. But because endothelial cells are deep within the body, they are normally only grown from tissue removed in surgery or post mortem, or from umbilical vessels after birth.
Because of this, current tests use endothelial cells taken from vessels of one donor, and white blood cells from a different donor. When cells from two different donors are used, one may have an immune reaction to the other, meaning the system is already primed for inflammation before the drug is added. This can result in the test falsely showing a severe immune reaction to a drug that is safe.
Researchers at Imperial College London got around this problem by isolating stem cells from the blood of a volunteer, and using them to grow endothelial cells in a dish. They then took white blood cells which they added to the donor’s own endothelial cells to recreate the unique conditions found in their blood vessels. When TGN1412 was added to the test tube, the mixture of cells released a cytokine storm, as would happen inside the body.
The new method is better as it only requires blood from one donor and doesn’t mix cells from different people, with the advantage of making a more reliable test.
Professor Jane Mitchell, from the National Heart and Lung Institute at Imperial College London, who led the study, said: “As biological therapies become more mainstream, it’s more likely that drugs being tested on humans for the first time will have unexpected and potentially catastrophic effects. We’ve used adult stem cell technology to develop a laboratory test that could prevent another disaster like the TGN1412 trial.
“Drug companies have the technical capacity to start using this test now, but we’re working on developing an off-the-shelf kit which will make it easy to use on a large scale.”
Dr Daniel Reed, the first author on the study, said: ”A further benefit of this new technology is that personalised therapies can be tested to see how safe and effective they will be for an individual.”
The Latest on: Personalised therapies
via Google News
The Latest on: Personalised therapies
- Patients' Own Bone Marrow Used in Personalized Therapy on April 18, 2019 at 10:52 am
Morristown Medical Center, part of Atlantic Health System, is the first and only hospital in New Jersey to enroll patients in the pivotal CardiAMP Heart Failure Trial. The Phase III clinical trial ... […]
- Personalized Cell Therapy Market Growth And Revenue Analysis By 2026 | Cytori Therapeutics, Bellicum Pharmaceuticals, Saneron CCEL Therapeutics on April 17, 2019 at 11:38 am
The patient-tailored therapies for the treatment of variety of disease are known as personalized cell therapy. The personalized cell therapy is based on genomic profile, and disease ... […]
- Personalized Medicine Progressing in Premenopausal Breast Cancer on April 17, 2019 at 8:14 am
Eight-year follow-up findings from the TEXT and SOFT trials provided considerable insight into the use of adjuvant endocrine therapy for women with premenopausal hormone receptor (HR)–positive breast ... […]
- Your Medicos Launches Personalized Integrative Medicine Treatment - Welcomes Specialist Carla Heiser and Team on April 17, 2019 at 8:09 am
The new program offered at Your Medicos will offer a variety of approaches, including personalized nutritional therapy and counseling, fitness training and physical therapy, neurological and allergy ... […]
- Microbiome science may help doctors deliver more effective, personalized treatment to children with irritable bowel syndrome on April 17, 2019 at 6:08 am
With this information, doctors envision tailoring nutritional and targeted therapies that address a child's specific ... Microbiome science may help doctors deliver more effective, personalized ... […]
- Personalized Medicine Market Size 2019 Production, Value, Supply and Demand Forecast 2024 on April 17, 2019 at 3:08 am
What does the Personalized Medicine market study enumerate considering ... Often it is used as part of combination therapy. It is not used for the prevention of malaria. The classification of ... […]
- Computational researchers and oncologists develop protein cancer atlas to accelerate personalized medicine for leukemia patients on April 17, 2019 at 1:08 am
It also propels researchers much closer to the development of personalized combination therapies for patients based on their unique protein signatures. “Acute myelogenous leukemia presents as a cancer ... […]
- Microbiome science may help doctors deliver more effective, personalized treatment to children with IBS on April 17, 2019 at 12:34 am
With this information, doctors envision tailoring nutritional and targeted therapies that address a child's specific gastrointestinal problems. "This research highlights the importance of the ... […]
- Genomic Assays Advance Personalized Care in Early-Stage Breast Cancer on April 16, 2019 at 9:05 am
In the interim, Chavez Mac Gregor explained that although these assays have helped shed light on what optimal adjuvant therapy looks like for patients ... cancer and shed light on the overall outlook ... […]
- New cancer therapies offer great hope, but there can be surprising complications on April 15, 2019 at 2:18 pm
When thinking about cancer therapy in recent years ... But we are moving out of an era of generalized cancer drugs and into the era of personalized oncology. New drugs target specific genes or ... […]
via Bing News